Pregabalin (All indications) updated on 04-22-2025

Therapeutic terminations of pregnancy

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17225
R72129		 Kaskal (Indications NOS), 2024 Medical termination of pregnancy during pregnancy (anytime or not specified) cohort unexposed (general population or NOS) Adjustment: No 6.34 [0.55;72.54] C 2/31   1/93 3 31
ref
Total 1 studies 6.34 [0.55;72.54] 3 31
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Kaskal (Indications NOS), 2024Kaskal, 2024 1 6.34[0.55; 72.54]3310%ROB confusion: criticalROB selection: unclearROB classification: unclearROB missing: unclearROB mesure: unclearROB reporting: moderate0.920.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Indications NOS;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 6.34[0.55; 72.54]331 -NAKaskal (Indications NOS), 2024 1 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 6.34[0.55; 72.54]331 -NAKaskal (Indications NOS), 2024 1 Tags Adjustment   - No  - No 6.34[0.55; 72.54]331 -NAKaskal (Indications NOS), 2024 1 All studiesAll studies 6.34[0.55; 72.54]331 -NAKaskal (Indications NOS), 2024 10.520.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 6.34[0.55; 72.54]331 -NAKaskal (Indications NOS), 2024 10.510.01.0